Thailand
8 Vaccines Approved for Use in Thailand
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: bnnbloomberg.ca
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
Approval Source: seekingalpha.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
14 in Clinical Trials in Thailand
Protein Subunit
SK Bioscience Co Ltd
GBP510
6 trials in 6 countries
Protein Subunit
Medigen
MVC-COV1901
Approved in 4 countries
15 trials in 4 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
RNA
Chulalongkorn University
ChulaCov19
5 trials in 2 countries
RNA
Chulalongkorn University
ChulaCov19-BNA159 mRNA Vaccine
2 trials in 1 country
Non Replicating Viral Vector
Mahidol University
NDV-HXP-S
7 trials in 3 countries
Protein Subunit
Baiya Phytopharm Co Ltd
Baiya SARS-CoV-2 Vax 1 Vaccine
Protein Subunit
Baiya Phytopharm Co Ltd
Baiya SARS-CoV-2 Vax 2
Protein Subunit
SK Bioscience Co Ltd
SKYCovione
Approved in 1 country
7 trials in 6 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries